Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Triapine anticancer therapy completes phase I trial

March 3, 2000

Schedule-dependent antitumor activity demonstrated for new modified steroidal lactams

March 3, 2000

ADIR's new MMP inhibitors particularly useful for cancer, rheumatoid arthritis

March 3, 2000

Pharmachemie presents new water-soluble tin compounds with excellent antitumor activity

March 3, 2000

CryoLife and Viragen enter cancer therapy collaboration

March 3, 2000

IL-4 gene therapy studied in malignant glioma

March 3, 2000

Maxygen enters CRADA with NCI for anticancer proteins

March 2, 2000

Several new approvals obtained for Gliadel

March 2, 2000

Feasibility of HSV-TK/GCV gene therapy demonstrated in glioblastoma multiforme

March 2, 2000

Aptosyn/Gemzar cancer trials to begin shortly

March 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...